Contractor
ADVANCED BIOSCIENCE LABORATORIES, INC.
- UEI
- MK4QC9EKZXG8
- Parent UEI
- WG3DJHG5C1C7
- Resolved by
- uei
- Confidence
- 1.000
Active from Jun 25, 2024 to Aug 4, 2026.
Recent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 75N93024F00001 EXPERTISE IN USING BITTER TASTE RECEPTOR BLOCKERS TO IMPROVE THE PALATABILITY OF PEDIATRIC MEDICINES: BLOCKER DISCOVERY | Department of Health and Human Services | MD | Jun 25, 2024 | $3,802,507 |
| 75N93024F00002 EXPERTISE IN USING BITTER TASTE RECEPTOR BLOCKERS TO IMPROVE THE PALATABILITY OF PEDIATRIC MEDICINES: TRAINED HUMAN SENSORY PANELS | Department of Health and Human Services | MD | Jun 25, 2024 | $2,413,956 |
| 75N93026F00001 SCALABLE, RELIABLE ARTIFICIAL INTELLIGENCE (AI)/MACHINE LEARNING (ML)- DRIVEN INTEGRATION AND INTERROGATION TO MODERNIZE THE STEP PEDIATRIC EXCIPIENT DATABASE | Department of Health and Human Services | MD | Jul 22, 2026 | $2,674,036 |
| HHSN272201700010I NIAID PRECLINICAL DEVELOPMENT SUPPORT | Department of Health and Human Services | — | Mar 30, 2026 | — |
| 75N93024F00002 LONG-TERM STABILITY TESTING OF A NANOPARTICLE BASED HIV ENVELOPE CONTAINING VACCINE | Department of Health and Human Services | MD | Jul 20, 2026 | $804,692 |
| 75N93023D00015 DIAGNOSTICS PRE-CLINICAL SERVICES PROGRAM IDIQ - ADVANCED BIOSCIENCE LAB | Department of Health and Human Services | — | Jul 17, 2026 | — |
| 75N93020F00002 TO ADMINISTRATE DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS. | Department of Health and Human Services | MD | Jul 16, 2026 | $2,226,090 |
| 75N95024D00013 EO 14398; IDIQ: CHEMISTRY, MANUFACTURING, AND CONTROL (CMC) AND RELATED SERVICES FOR DRUG PRODUCTS (TRND 3) | Department of Health and Human Services | — | Jul 16, 2026 | — |
| 75N93022D00004 EO 14398 THE CONTRACTOR SHALL PROVIDE NIAID WITH A BROAD AND FLEXIBLE RANGE OF CAPABILITIES THAT ARE REQUIRED FOR PRECLINICAL AND TRANSLATIONAL DEVELOPMENT SUPPORT FOR PROMISING VACCINES AND RELATED PRODUCTS FOR HIV AND OTHER CANDIDATE AGENTS. | Department of Health and Human Services | — | Jul 13, 2026 | — |
| 75N95024D00028 PHARMACOLOGY STUDIES AND ANIMAL MODEL DEVELOPMENT AND RELATED SERVICES FOR DRUG DEVELOPMENT | Department of Health and Human Services | — | Jul 13, 2026 | — |
| 75N93023F00002 MATERIAL AND DATA RECEIPT, STORAGE, SHIPPING, AND INVENTORY | Department of Health and Human Services | MD | Jul 9, 2026 | $259,754 |
| 75N95024D00008 EO 14398 | Department of Health and Human Services | — | Jul 7, 2026 | — |
| 75N93023D00001 EO 14398 | Department of Health and Human Services | — | Jul 6, 2026 | — |
| 75N93023F00001 CGMP MANUFACTURING OF PGT121.414.LS MAB - NIAID PRECLINICAL DEVELOPMENT SUPPORT EOI::EO:RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING | Department of Health and Human Services | MD | Jun 17, 2026 | $17,241,407 |
| 75N93024F00001 ESSENTIAL CORE ACTIVITIES III | Department of Health and Human Services | MD | Jun 4, 2026 | $1,555,875 |
| 75N93018F00015 THE CONTRACTOR SHALL PROVIDE EXPERTISE IN ETHNOGRAPHIC RESEARCH RELATED TO THE ENHANCEMENT OF STUDY DRUG ADHERENCE AND UPTAKE IN HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION TRIALS. | Department of Health and Human Services | MD | May 26, 2026 | $537,740 |
| HHSN27200007 NONHUMAN PRIMATE PURCHASE AND HOLDING | Department of Health and Human Services | MD | May 26, 2026 | $6,072,227 |
| HHSN27200003 MATERIAL RECEIPT, STORAGE, SHIPPING AND INVENTORY | Department of Health and Human Services | MD | May 26, 2026 | $530,846 |
| 75N93019F00133 THE CONTRACTOR SHALL PROVIDE STATISTICAL AND PHARMACOMETRIC MODELING SUPPORT FOR HIV NONVACCINE BIOMEDICAL PREVENTION PRODUCT DEVELOPMENT | Department of Health and Human Services | MD | May 26, 2026 | $807,259 |
| 75N93018F00011 NIAID PRECLINICAL DEVELOPMENT SUPPORT - NIAID PRECLINICAL DEVELOPMENT SUPPORT: PRODUCTION AND PROCUREMENT OF DELTA INULIN AND CPG ADJUVANTS | Department of Health and Human Services | MD | May 14, 2026 | $2,407,110 |
| 75N93022F00001 ABL MANUFACTURE AND CHARACTERIZATION SERVICES (MCS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES | Department of Health and Human Services | MD | Apr 2, 2026 | $3,752,675 |
| 75N93018F00009 NIAID PRECLINICAL DEVELOPMENT SUPPORT- CGMP MANUFACTURING OF PGT121 AND PGDM1400 ANTIBODIES | Department of Health and Human Services | MD | Mar 30, 2026 | $12,942,880 |
| 75N93023F00001 QUALITY ASSURANCE/QUALITY CONTROL (QA/QC) SUPPORT | Department of Health and Human Services | MD | Mar 30, 2026 | $2,171,969 |
| HHSN27200003 PRODUCTION OF ALUMINUM BASED ADJUVANTS | Department of Health and Human Services | MD | Mar 4, 2026 | $2,102,618 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier MK4QC9EKZXG8, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Aug 10, 2026.